About active pharmaceutical ingredient manufacturers
This kind of carryover must not bring about the carryover of degradants or microbial contamination that may adversely alter the founded API impurity profile.Acceptance conditions for residues and the choice of cleaning strategies and cleansing agents need to be defined and justified.Processing aids, harmful or very poisonous raw materials, other Sp